You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 6,667,041

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,667,041

Title:	Use of neurotoxin therapy for treatment of urologic and related disorders
Abstract:	The present invention relates to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin.
Inventor(s):	Schmidt; Richard A. (Arvada, CO)
Assignee:	The Regents of the University of Colorado (Boulder, CO)
Application Number:	09/978,982
Patent Claims:	1. A method of treating urinary incontinence in mammals comprising the step of administering to a mammal that has at least one symptom of urinary incontinence a therapeutically effective amount of a botulinum toxin, thereby treating at least one symptom of urinary incontinence in said mammal. 2. The method according to claim 1, wherein the mammal is a human male. 3. The method of claim 1, wherein the urinary incontinence is selected form the group consisting of unstable bladder and unstable sphincter. 4. The method of claim 1, wherein the botulinum toxin is botulinum toxin type A. 5. A method for treating a urinary incontinence disorder, the method comprising the step of local administration of a botulinum toxin into the urinary tract of a patient that has at least one symptom of urinary incontinence, thereby treating a symptom of urinary incontinence in the patient. 6. The method of claim 5, wherein the botulinum toxin is botulinum toxin A. 7. The method of claim 1, wherein the botulinum toxin is administered to the bladder of the mammal. 8. The method of claim 5, wherein the botulinum toxin is administered to the bladder of the patient.

Details for Patent 6,667,041

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Allergan, Inc.	BOTOX COSMETIC	onabotulinumtoxina	For Injection	103000	12/09/1991	⤷ Try a Trial	2017-07-15
Allergan, Inc.	BOTOX	onabotulinumtoxina	For Injection	103000	12/09/1991	⤷ Try a Trial	2017-07-15
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 6,667,041

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Austria	314085	⤷ Try a Trial
Austria	320815	⤷ Try a Trial
Austria	339220	⤷ Try a Trial
Austria	448792	⤷ Try a Trial
Austria	552006	⤷ Try a Trial
Australia	2005234633	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.